1.13. Analysis.
Comparison 1 Adrenergic agonist vs placebo, Outcome 13 Adverse events ‐ cross‐over trial #.
| Adverse events ‐ cross‐over trial # | ||
|---|---|---|
| Study | Adrenergic drug | Placebo |
| Phenylpropanolamine vs placebo | ||
| Ani 1987 # | 4/22 (of whom 2 dropped out) | 0/20 |
| Collste 1987 # | 3/24 | 3/24 |
| Hilton 1982 # | 11/22 | 1/22 |
| Norepinephrine vs placebo | ||
| Ek 1978 # | 5/22 Withdrew: 2/25 | 0/22 Withdrew: 1/25 |
| Ro 115‐1240 vs placebo | ||
| Musselman 2004 # | 30/36 | 26/36 |
| Terbutaline vs placebo | ||
| Kromann 1991 # | 4/17 | 2/17 |